National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

dolasetron mesylate
An indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, dolasetron mesylate competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Anzemet
Code name:MDL 73,147EF



Previous:DJ-927, DM4-conjugated anti-Cripto monoclonal antibody BIIB015, DNA plasmid vector pPRA-PSM vaccine, docetaxel, docetaxel emulsion ANX-514
Next:dolastatin 10, Dolophine, Domestrol, Domolene-HC, donepezil hydrochloride

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov